Publication

Engineering antigens for in situ erythrocyte binding induces T-cell deletion

Related publications (62)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Engineering antigens for in situ erythrocyte binding induces T-cell deletion

Graph Chatbot

Chat with Graph Search

Early-life vitamin A treatment rescues neonatal infection-induced durably impaired tolerogenic properties of celiac lymph nodes

Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release

High-affinity peptides developed against calprotectin and their application as synthetic ligands in diagnostic assays

Cysteine-Cysteine Cross-Conjugation of both Peptides and Proteins with a Bifunctional Hypervalent Iodine-Electrophilic Reagent

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

Biotechnologies to tackle the challenge of neoantigen identification

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes

Introducing tolerance to foreign and partly foreign proteins by erythrocyte binding and artificial glycosylations

New roles of the lymphatic endothelium in modulating adaptive immunity: implications for immune tolerance and cancer immunotherapy